Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib + HAIC (FOLFOX vs OXA) in HCC with PVTT
NCT03468231Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Mar 2018
- Primary completion
- Sep 2019
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, fluorouracil, folinic acid in hepatocellular carcinoma (HCC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
oxaliplatinfluorouracilfolinic acid
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03468231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03468231.